Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125816471 | 12581647 | 1 | I | 20150817 | 20160722 | 20160722 | PER | US-STRIDES ARCOLAB LIMITED-2015SP001156 | STRIDES | 0.00 | Y | 0.00000 | 20160722 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125816471 | 12581647 | 1 | PS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 1000 MG, PRIOR TO SURGERY | 90055 | 1000 | MG | |||||||||
| 125816471 | 12581647 | 2 | SS | MYCOPHENOLATE MOFETIL. | MYCOPHENOLATE MOFETIL | 1 | 1000 MG AT FIRST PTM | 90055 | 1000 | MG | |||||||||
| 125816471 | 12581647 | 3 | C | TACROLIMUS. | TACROLIMUS | 1 | 6 MG, BID AT FIRST PTM | 0 | 6 | MG | |||||||||
| 125816471 | 12581647 | 4 | C | TACROLIMUS. | TACROLIMUS | 1 | 4 MG, BID AT 6TH PTM | 0 | 4 | MG | |||||||||
| 125816471 | 12581647 | 5 | C | TACROLIMUS. | TACROLIMUS | 1 | 2 MG, BID AT 12TH PTM | 0 | 2 | MG | |||||||||
| 125816471 | 12581647 | 6 | C | TACROLIMUS. | TACROLIMUS | 1 | 2 MG, BID AT 18TH PTM | 0 | 2 | MG | |||||||||
| 125816471 | 12581647 | 7 | C | TACROLIMUS. | TACROLIMUS | 1 | 1.5 MG, BID AT 24 PTM | 0 | 1.5 | MG | |||||||||
| 125816471 | 12581647 | 8 | C | TACROLIMUS. | TACROLIMUS | 1 | 2.5 MG, BID AT 36TH PTM | 0 | 2.5 | MG | |||||||||
| 125816471 | 12581647 | 9 | C | PREDNISONE. | PREDNISONE | 1 | 20 MG, ON DAY 5 | 0 | 20 | MG | |||||||||
| 125816471 | 12581647 | 10 | C | ALEMTUZUMAB | ALEMTUZUMAB | 1 | UNK | 0 | |||||||||||
| 125816471 | 12581647 | 11 | C | ANTITHYMOCYTE IMMUNOGLOBULIN | THYMOCYTE IMMUNE GLOBULIN NOS | 1 | 1.5MG/KG/DAY X 4 DAYS | 0 | |||||||||||
| 125816471 | 12581647 | 12 | C | METHYLPREDNISOLONE. | METHYLPREDNISOLONE | 1 | 500 MG, QD | 0 | 500 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125816471 | 12581647 | 1 | Immunosuppression |
| 125816471 | 12581647 | 3 | Immunosuppression |
| 125816471 | 12581647 | 9 | Immunosuppression |
| 125816471 | 12581647 | 10 | Immunosuppression |
| 125816471 | 12581647 | 11 | Immunosuppression |
| 125816471 | 12581647 | 12 | Immunosuppression |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125816471 | 12581647 | Diarrhoea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |